Cisplatin and Hyperplasia - a phase IV clinical study of FDA data

Summary:

Hyperplasia is reported as a side effect among people who take Cisplatin (cisplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Lung adenocarcinoma.

The phase IV clinical study analyzes which people have Hyperplasia when taking Cisplatin. It is created by eHealthMe based on reports of 92,672 people who have side effects when taking Cisplatin from the FDA, and is updated regularly.

What is Cisplatin?

Cisplatin has active ingredients of cisplatin. It is often used in chemotherapy. eHealthMe is studying from 92,837 Cisplatin users. Check the latest studies of Cisplatin.

What is Hyperplasia?

Hyperplasia (enlargement of an organ or tissue) is found to be associated with 315 drugs and 427 conditions by eHealthMe. Check the latest studies of Hyperplasia.

On Jul, 05, 2026

92,672 people reported to have side effects when taking Cisplatin.
Among them, 14 people (0.02%) have Hyperplasia.

Among these 14 people:

How long have people been on Cisplatin when they have Hyperplasia? *

What is the gender of people who have Hyperplasia when taking Cisplatin? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Hyperplasia when taking Cisplatin? *

What are other drugs people take besides Cisplatin? *

Vincristine Sulfate: 3 people, 21.43%
Cyclophosphamide: 3 people, 21.43%
Morphine Sulfate: 2 people, 14.29%
Dexamethasone Sodium Phosphate: 2 people, 14.29%
Etoposide: 2 people, 14.29%
Fluorouracil: 1 person, 7.14%
Ambien: 1 person, 7.14%
Aredia: 1 person, 7.14%
Ativan: 1 person, 7.14%
Avastin: 1 person, 7.14%

What are other side effects people have besides Hyperplasia? *

Oedema Peripheral (superficial swelling): 3 people, 21.43%
Haemoglobin Decreased: 2 people, 14.29%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Red Blood Cell Count Decreased: 2 people, 14.29%
Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 2 people, 14.29%
White Blood Cell Count Increased: 2 people, 14.29%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 2 people, 14.29%
Swallowing Difficulty: 2 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 2 people, 14.29%

What are the existing conditions these people have? *

Oral Cavity Cancer Metastatic (cancer of mouth spreads to other part): 1 person, 7.14%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.14%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Cisplatin and have Hyperplasia?

- Check whether Hyperplasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cisplatin:

Cisplatin (92,837 reports)

Hyperplasia treatments and more:

Hyperplasia (1,530 reports)

Browse all side effects of Cisplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperplasia:

Hyperplasia (315 drugs)

Browse all the conditions that are associated with Hyperplasia:

Hyperplasia (427 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cisplatin (the active ingredients of Cisplatin) and Cisplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.